Literature DB >> 19176371

Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9.

Heesang Song1, Yonghe Li, Jiyeon Lee, Alan L Schwartz, Guojun Bu.   

Abstract

The low-density lipoprotein receptor-related protein 1 (LRP1) is a multifunctional endocytic receptor involved in the metabolism of various extracellular ligands, including proteinases, that play critical roles in tumor invasion. Although several studies have shown an increased expression of LRP1 in cancer cells, its function in tumor development and progression remains largely unclear. Here, we reveal a novel mechanism by which LRP1 induces the expression of matrix metalloproteinase 2 (MMP2) and MMP9 and thereby promotes the migration and invasion of human glioblastoma U87 cells. Knockdown of LRP1 expression greatly decreased U87 cell migration and invasion, which was rescued by the forced expression of a functional LRP1 minireceptor. Inhibition of ligand binding to LRP1 by a specific antagonist, receptor-associated protein, also led to reduced cancer cell migration and invasion. Because MMPs play critical roles in cancer cell migration and invasion, we examined the expression of several MMPs and found that the expression of functional MMP2 and MMP9 was selectively decreased in LRP1 knockdown cells. More importantly, decreased cell migration and invasion of LRP1 knockdown cells were completely rescued by exogenous expression of MMP2 or MMP9, suggesting that these MMPs are likely downstream targets of LRP1-mediated signaling. We further show that the level of phosphorylated extracellular signal-regulated kinase (ERK) was significantly decreased in LRP1-silenced cells, suggesting that ERK is a potential mediator of LRP1-regulated MMP2 and MMP9 expression in U87 cells. Together, our data strongly suggest that LRP1 promotes glioblastoma cell migration and invasion by regulating the expression and function of MMP2 and MMP9 perhaps via an ERK-dependent signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19176371      PMCID: PMC2633434          DOI: 10.1158/0008-5472.CAN-08-3379

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

Review 1.  Regulation of matrix metalloproteinase expression in tumor invasion.

Authors:  J Westermarck; V M Kähäri
Journal:  FASEB J       Date:  1999-05       Impact factor: 5.191

2.  Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion.

Authors:  S S Okada; S R Grobmyer; E S Barnathan
Journal:  Arterioscler Thromb Vasc Biol       Date:  1996-10       Impact factor: 8.311

Review 3.  Changing views of the role of matrix metalloproteinases in metastasis.

Authors:  A F Chambers; L M Matrisian
Journal:  J Natl Cancer Inst       Date:  1997-09-03       Impact factor: 13.506

4.  Embryonic fibroblasts that are genetically deficient in low density lipoprotein receptor-related protein demonstrate increased activity of the urokinase receptor system and accelerated migration on vitronectin.

Authors:  A M Weaver; I M Hussaini; A Mazar; J Henkin; S L Gonias
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

5.  Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion.

Authors:  C Simon; H Goepfert; D Boyd
Journal:  Cancer Res       Date:  1998-03-15       Impact factor: 12.701

6.  Receptor-associated protein is a folding chaperone for low density lipoprotein receptor-related protein.

Authors:  G Bu; S Rennke
Journal:  J Biol Chem       Date:  1996-09-06       Impact factor: 5.157

7.  The migration of human smooth muscle cells in vitro is mediated by plasminogen activation and can be inhibited by alpha2-macroglobulin receptor associated protein.

Authors:  M J Wijnberg; P H Quax; N M Nieuwenbroek; J H Verheijen
Journal:  Thromb Haemost       Date:  1997-08       Impact factor: 5.249

8.  Receptor-mediated endocytosis of tissue-type plasminogen activator by low density lipoprotein receptor-related protein on human hepatoma HepG2 cells.

Authors:  G Bu; E A Maksymovitch; A L Schwartz
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

9.  Decreased expression of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in invasive cell clones derived from human prostate and breast tumor cells.

Authors:  R K Kancha; M E Stearns; M M Hussain
Journal:  Oncol Res       Date:  1994       Impact factor: 5.574

10.  Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.

Authors:  P A Forsyth; H Wong; T D Laing; N B Rewcastle; D G Morris; H Muzik; K J Leco; R N Johnston; P M Brasher; G Sutherland; D R Edwards
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

View more
  79 in total

Review 1.  Lipoprotein receptors--an evolutionarily ancient multifunctional receptor family.

Authors:  Marco Dieckmann; Martin Frederik Dietrich; Joachim Herz
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

2.  Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake.

Authors:  Takahisa Kanekiyo; Juan Zhang; Qiang Liu; Chia-Chen Liu; Lijuan Zhang; Guojun Bu
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

3.  Apolipoprotein E Inhibits Cerebrovascular Pericyte Mobility through a RhoA Protein-mediated Pathway.

Authors:  Caroline S Casey; Yuka Atagi; Yu Yamazaki; Mitsuru Shinohara; Masaya Tachibana; Yuan Fu; Guojun Bu; Takahisa Kanekiyo
Journal:  J Biol Chem       Date:  2015-04-22       Impact factor: 5.157

4.  The active contribution of OPCs to neuroinflammation is mediated by LRP1.

Authors:  Anthony Fernández-Castañeda; Megan S Chappell; Dorian A Rosen; Scott M Seki; Rebecca M Beiter; David M Johanson; Delaney Liskey; Emily Farber; Suna Onengut-Gumuscu; Christopher C Overall; Jeffrey L Dupree; Alban Gaultier
Journal:  Acta Neuropathol       Date:  2019-09-24       Impact factor: 17.088

5.  Radioiodinated Small-Molecule Tyrosine Kinase Inhibitor for HER2-Selective SPECT Imaging.

Authors:  Longguang Tang; Chenyu Peng; Bowen Tang; Zijing Li; Xiangyu Wang; Jindian Li; Fei Gao; Lumei Huang; Duo Xu; Pu Zhang; Rongqiang Zhuang; Xinhui Su; Xiaoyuan Chen; Xianzhong Zhang
Journal:  J Nucl Med       Date:  2018-04-13       Impact factor: 10.057

6.  MicroRNA-205 inhibits tumor cell migration through down-regulating the expression of the LDL receptor-related protein 1.

Authors:  Heesang Song; Guojun Bu
Journal:  Biochem Biophys Res Commun       Date:  2009-08-08       Impact factor: 3.575

Review 7.  Biology of angiogenesis and invasion in glioma.

Authors:  Matthew C Tate; Manish K Aghi
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 8.  LDL receptor-related protein-1: a regulator of inflammation in atherosclerosis, cancer, and injury to the nervous system.

Authors:  Steven L Gonias; W Marie Campana
Journal:  Am J Pathol       Date:  2013-10-12       Impact factor: 4.307

9.  LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathways.

Authors:  Benoit Langlois; Gwenn Perrot; Christophe Schneider; Patrick Henriet; Hervé Emonard; Laurent Martiny; Stéphane Dedieu
Journal:  PLoS One       Date:  2010-07-14       Impact factor: 3.240

10.  LRP-1 Pathway Targeted Inhibition of Vascular Abnormalities in the Retina of Diabetic Mice.

Authors:  Ahamed Hossain; Lamiya Tauhid; Ian Davenport; Thomas Huckaba; Richard Graves; Tarun Mandal; Syed Muniruzzaman; Syed A Ahmed; Partha S Bhattacharjee
Journal:  Curr Eye Res       Date:  2016-07-21       Impact factor: 2.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.